Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Altimmune Debt to Equity Ratio 2011-2025 | ALT

Current and historical debt to equity ratio values for Altimmune (ALT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Altimmune debt/equity for the three months ending June 30, 2025 was 0.09.
Altimmune Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2025-06-30 $0.03B $0.16B 0.18
2025-03-31 $0.02B $0.14B 0.11
2024-12-31 $0.02B $0.12B 0.13
2024-09-30 $0.01B $0.13B 0.11
2024-06-30 $0.02B $0.15B 0.14
2024-03-31 $0.02B $0.17B 0.09
2023-12-31 $0.02B $0.19B 0.09
2023-09-30 $0.02B $0.15B 0.11
2023-06-30 $0.02B $0.17B 0.09
2023-03-31 $0.02B $0.17B 0.12
2022-12-31 $0.02B $0.19B 0.12
2022-09-30 $0.02B $0.21B 0.10
2022-06-30 $0.02B $0.20B 0.08
2022-03-31 $0.02B $0.19B 0.11
2021-12-31 $0.02B $0.20B 0.10
2021-09-30 $0.03B $0.21B 0.13
2021-06-30 $0.02B $0.24B 0.07
2021-03-31 $0.02B $0.25B 0.07
2020-12-31 $0.02B $0.23B 0.09
2020-09-30 $0.03B $0.20B 0.17
2020-06-30 $0.02B $0.08B 0.29
2020-03-31 $0.01B $0.04B 0.29
2019-12-31 $0.01B $0.05B 0.19
2019-09-30 $0.01B $0.05B 0.14
2019-06-30 $0.01B $0.06B 0.10
2019-03-31 $0.01B $0.06B 0.10
2018-12-31 $0.01B $0.05B 0.13
2018-09-30 $0.01B $0.04B 0.33
2018-06-30 $0.02B $0.04B 0.44
2018-03-31 $0.01B $0.05B 0.31
2017-12-31 $0.02B $0.04B 0.60
2017-09-30 $0.03B $0.05B 0.52
2017-06-30 $0.02B $0.08B 0.20
2017-03-31 $0.00B $0.02B 0.15
2016-12-31 $0.01B $0.03B 0.19
2016-09-30 $0.00B $0.14B 0.03
2016-06-30 $0.00B $0.02B 0.15
2016-03-31 $0.00B $0.02B 0.20
2015-12-31 $0.00B $0.02B 0.19
2015-09-30 $0.00B $0.02B 0.18
2015-06-30 $0.00B $0.02B 0.23
2015-03-31 $0.01B $0.02B 0.27
2014-12-31 $0.00B $0.02B 0.20
2014-09-30 $0.01B $0.02B 0.29
2014-06-30 $0.00B $0.01B 0.40
2014-03-31 $0.01B $0.01B 0.73
2013-12-31 $0.01B $0.01B 1.34
2013-09-30 $0.01B $0.01B 0.82
2013-06-30 $0.01B $0.01B 0.86
2013-03-31 $0.01B $0.01B 1.21
2012-12-31 $0.01B $0.01B 0.95
2012-09-30 $0.01B $0.01B 0.87
2012-06-30 $0.01B $0.01B 0.76
2012-03-31 $0.01B $0.01B 0.80
2011-12-31 $0.01B $0.02B 0.44
2011-09-30 $0.01B $0.02B 0.49
2011-06-30 $0.01B $0.01B 0.87
2011-03-31 $0.01B $0.01B 1.20
2010-12-31 $0.02B $0.01B 1.23
2010-09-30 $0.03B $-0.01B -2.90
2010-06-30 $0.03B $-0.01B -3.49
2010-03-31 $0.03B $-0.01B -6.47
2009-12-31 $0.03B $0.00B 10.21
2009-09-30 $0.04B $0.01B 5.47
2009-06-30 $0.03B $0.01B 3.16
2009-03-31 $0.04B $0.02B 2.24
2008-12-31 $0.04B $0.02B 1.97
2008-09-30 $0.04B $0.01B 3.50
2008-06-30 $0.04B $0.02B 2.65
2008-03-31 $0.03B $0.04B 0.72
2007-12-31 $0.03B $0.04B 0.64
2007-09-30 $0.03B $0.04B 0.65
2007-06-30 $0.00B 0.00
2007-03-31 $0.02B $0.06B 0.26
2006-12-31 $0.09B $-0.07B -1.21
2006-09-30 $0.01B $0.06B 0.25
2006-06-30 $0.01B $0.06B 0.25
2006-03-31 $0.01B $0.06B 0.25
2005-12-31 $0.00B 0.00
2005-09-30 $0.01B $0.06B 0.25
2005-06-30 $0.00B $0.00B 7.98
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.429B $0.000B
Altimmune, Inc. is a clinical-stage immunotherapeutics company. It focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The company's proprietary platform technologies consist of RespirVec and Densigen. Altimmune Inc., formerly known as Pharmathene Inc., is based in Gaithersburg, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.709B 30.27
Zoetis (ZTS) United States $52.989B 18.97
Takeda Pharmaceutical (TAK) Japan $43.466B 8.87
Daiichi Sankyo, - (DSNKY) Japan $41.562B 20.70
BeOne Medicines - (ONC) Switzerland $35.089B 186.03
Sandoz Group AG (SDZNY) Switzerland $29.014B 0.00
United Therapeutics (UTHR) United States $19.329B 17.01
Merck (MKKGY) Germany $16.401B 10.66
Neurocrine Biosciences (NBIX) United States $15.192B 36.45
Shionogi (SGIOY) Japan $14.411B 13.23
Summit Therapeutics (SMMT) United States $14.020B 0.00
Ionis Pharmaceuticals (IONS) United States $11.913B 0.00
IPSEN (IPSEY) France $11.841B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.112B 0.00
Orion OYJ (ORINY) Finland $8.719B 24.91
Eisai (ESAIY) $8.166B 0.00
Corcept Therapeutics (CORT) United States $7.754B 83.77
Stevanato Group S.p.A (STVN) Italy $7.299B 40.85
Grifols, S.A (GRFS) Spain $5.803B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.546B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.140B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.767B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.571B 16.97
Centessa Pharmaceuticals (CNTA) United Kingdom $2.962B 0.00
Hypermarcas (HYPMY) Brazil $2.958B 22.24
Catalyst Pharmaceuticals (CPRX) United States $2.629B 8.39
Dyne Therapeutics (DYN) United States $2.622B 0.00
Soleno Therapeutics (SLNO) United States $2.562B 0.00
Ocular Therapeutix (OCUL) United States $2.312B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.926B 22.83
Guardian Pharmacy Services (GRDN) United States $1.824B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.815B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.493B 88.62
Ardelyx (ARDX) United States $1.358B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.352B 0.00
Collegium Pharmaceutical (COLL) United States $1.337B 6.62
Harrow (HROW) United States $1.255B 0.00
Xeris Biopharma Holdings (XERS) United States $1.233B 0.00
Oruka Therapeutics (ORKA) United States $1.153B 0.00
Evotec AG (EVO) Germany $1.094B 0.00
Nektar Therapeutics (NKTR) United States $1.064B 0.00
Relay Therapeutics (RLAY) United States $1.049B 0.00
Enliven Therapeutics (ELVN) United States $1.044B 0.00
Xencor (XNCR) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.950B 0.00
ARS Pharmaceuticals (SPRY) United States $0.875B 0.00
ProKidney (PROK) United States $0.850B 0.00
Theravance Biopharma (TBPH) United States $0.743B 61.46
Aquestive Therapeutics (AQST) United States $0.737B 0.00
Organogenesis (ORGO) United States $0.714B 0.00
Savara (SVRA) United States $0.683B 0.00
Elite Pharmaceuticals (ELTP) United States $0.674B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.639B 5.70
Bioventus (BVS) United States $0.616B 12.63
KalVista Pharmaceuticals (KALV) United States $0.545B 0.00
Akebia Therapeutics (AKBA) United States $0.541B 0.00
Esperion Therapeutics (ESPR) United States $0.536B 0.00
Zevra Therapeutics (ZVRA) United States $0.496B 0.00
4D Molecular Therapeutics (FDMT) United States $0.490B 0.00
Siga Technologies (SIGA) United States $0.468B 6.41
Lexeo Therapeutics (LXEO) United States $0.442B 0.00
USANA Health Sciences (USNA) United States $0.350B 9.76
Lyell Immunopharma (LYEL) United States $0.336B 0.00
Galectin Therapeutics (GALT) United States $0.335B 0.00
Korro Bio (KRRO) United States $0.318B 0.00
Nature's Sunshine Products (NATR) United States $0.314B 18.67
Ironwood Pharmaceuticals (IRWD) United States $0.312B 48.00
Larimar Therapeutics (LRMR) United States $0.286B 0.00
Aldeyra Therapeutics (ALDX) United States $0.282B 0.00
Aclaris Therapeutics (ACRS) United States $0.251B 0.00
Achieve Life Sciences (ACHV) Canada $0.244B 0.00
Pyxis Oncology (PYXS) United States $0.243B 0.00
Journey Medical (DERM) United States $0.240B 0.00
AleAnna (ANNA) United States $0.212B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
OmniAb (OABI) United States $0.199B 0.00
Avalo Therapeutics (AVTX) United States $0.198B 0.00
MediWound (MDWD) Israel $0.195B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
Protara Therapeutics (TARA) United States $0.166B 0.00
China SXT Pharmaceuticals (SXTC) China $0.159B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.149B 0.00
Cassava Sciences (SAVA) United States $0.143B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
Incannex Healthcare (IXHL) Australia $0.121B 0.00
Inhibikase Therapeutics (IKT) United States $0.112B 0.00
Surrozen (SRZN) United States $0.105B 0.00
Context Therapeutics (CNTX) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Avita Medical (RCEL) United States $0.100B 0.00
Vivani Medical (VANI) United States $0.096B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.093B 33.70
Karyopharm Therapeutics (KPTI) United States $0.088B 0.00
Relmada Therapeutics (RLMD) United States $0.088B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Lite Strategy (LITS) United States $0.075B 0.00
Plus Therapeutics (PSTV) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.073B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.071B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Prelude Therapeutics (PRLD) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.067B 0.00
BioNxt Solutions (BNXTF) Canada $0.060B 0.00
Acrivon Therapeutics (ACRV) United States $0.059B 0.00
PolyPid (PYPD) Israel $0.058B 0.00
Talphera (TLPH) United States $0.058B 0.00
Wellgistics Health (WGRX) United States $0.057B 0.00
Fractyl Health (GUTS) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
ElectroCore (ECOR) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Inotiv (NOTV) United States $0.040B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 26.62
Liminatus Pharma (LIMN) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Mangoceuticals (MGRX) United States $0.023B 0.00
Cosmos Health (COSM) United States $0.021B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Vyome Holdings (HIND) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Heatwurx (PCSA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Lipocine (LPCN) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.02
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.99
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00